RxDoctor Payments Data

Wael Hussein

Nephrology · Memphis, TNNPI 1104172378

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,750 of the $10,071 with a category attached, or 96.8%. GSK accounts for 97.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $9,829 and has fallen 98.6% since, to $142 in 2025.

$10,071in general payments, 2019–2025

Across 9 payments — averaging $1118.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$10K
  • Nxstage Medical, Inc.$100
  • Calliditas Therapeutics US Inc.$63
  • Bayer$56
  • Aurinia Pharma U.S., Inc.$23
$907,217in research payments, 2019–2025

Across 295 payments — averaging $3075.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Quanta Dialysis Technologies Inc$726K
  • CSL Behring$99K
  • Baxter Healthcare$82K

What the payments were for

  • Consulting fees$9,75097%
  • Travel & lodging$791%
  • Food & beverage$2412%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,071 in reported general payments places this provider in the 85th percentile of 229 nephrology providers in Tennessee.

See all nephrology providers in Tennessee

Other nephrology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →